Environmental public health surveillance: possible estuary-associated syndrome. by Backer, L C et al.
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 5 | October 2001 797
Introduction
Public Health Surveillance
Public health surveillance involves the
collection, analysis, and dissemination of data
on speciﬁc health effects (e.g., disease, disabil-
ity) for use in public health practice (1). A sur-
veillance system includes the capacity to
collect and analyze data as well as the ability to
disseminate the data in a timely manner to
public health agencies that can then undertake
effective prevention and control activities.
Surveillance can be established to assess
public health status, to establish public health
priorities, to evaluate programs, and to con-
duct research (2). Surveillance data can be
used to estimate the magnitude of a health
problem in the population at risk, inform the
population at risk of exposure or illness,
inform persons and organizations responsible
for immediate control measures and other
interventions, understand the natural history
of an illness or injury, detect outbreaks or epi-
demics, and document the distribution and
spread of a health event. The data can also be
used to test hypotheses about etiology, evalu-
ate control strategies, monitor changes in
exposure, identify research needs, facilitate
epidemiological and laboratory research, facil-
itate planning, and provide information for
decision making and policy (2).
Surveillance systems collecting primary
data are classified as either passive or active
(2). A passive system receives reports from
physicians, individuals, or institutions,
whereas an active system regularly contacts
previously identiﬁed sources to elicit reports.
Clearly, an active system results in more com-
plete reporting; however, this type of surveil-
lance is labor intensive and costly.
Surveillance systems prospectively identify
the particular outcome of interest. Most sur-
veillance systems also collect at least limited
demographic information about the affected
people, details about the health event, and the
presence or absence of the appropriate risk
factors (3).
Environmental Public Health
Surveillance
In environmental public health, surveillance
activities are applied not only to health out-
comes but also to environmental hazards and
exposures (4). For a surveillance system to be
applicable to an environmental public health
concern, the system must include measure-
ments of specific hazards (e.g., water pollu-
tion), exposures (e.g., biomarkers for levels of
an environmental contaminant in blood or
other tissues), and/or health outcomes (4).
The system must produce an ongoing data
record rather than one-time surveys, and it
must produce timely and representative data
for use by agencies responsible for addressing
environmental public health issues (4).
A number of special issues are associated
with environmental public health surveillance
(4), including a limited ability to identify the
speciﬁc environmental causes of many adverse
outcomes, particularly if the latency period is
very long. In addition, we often attempt to
conduct environmental public health surveil-
lance using data collected for other purposes
(e.g., vital records or drinking water quality
monitoring) that do not contain adequate
information to meet a case definition for an
illness associated with an environmental
exposure.
Another important issue to be addressed
when conducting environmental public
health surveillance is the need to involve a
number of different constituencies in public
health activities. Public alarm can inﬂuence a
public health agenda by inﬂuencing not only
funding decisions but also the directions of
scientiﬁc research. Including input from spe-
ciﬁc interest and community activist groups,
as well as the public health community, may
improve the success of an environmental
health surveillance program.
Public health surveillance involves the collection, analysis, and dissemination of data for use in public
health practice. A surveillance system includes the capacity to collect and analyze data as well as the
ability to disseminate the data to public health agencies that can undertake effective prevention and
control activities. An emerging issue in environmental public health surveillance involves human
exposure to the toxins produced by microorganisms present in oceans and estuaries. One of these
organisms is Pﬁesteria piscicida Steidinger & Burkholder, a dinoﬂagellate found in estuaries along the
Atlantic and gulf coasts of the United States. There have been reports of both human illness
associated with occupational exposures to concentrated laboratory cultures of P. piscicida and
massive ﬁll kills associated with the presence of the organism in rivers and estuaries. These reports,
and anecdotal reports from people who worked on rivers where the organism has been found,
generated concern that environmental exposures to P. piscicida, similar organisms, or perhaps a
toxin or toxins produced by the organism(s), could cause adverse human health effects. To begin to
evaluate the public health burden associated with P. piscicida, investigators from the National Center
for Environmental Health at Centers for Disease Control and Prevention and health agencies from
states along the Atlantic coast collaborated to develop a passive surveillance system for collecting,
classifying, and tracking public inquiries about the organism. Speciﬁcally, the group developed
exposure and symptom criteria and developed data collection and reporting capabilities to capture
the human health parameters collectively referred to as possible estuary-associated syndrome
(PEAS). The surveillance system was implemented in six states (Delaware, Florida, Maryland, North
Carolina, South Carolina, Virginia) beginning in June 1998. From 1 June 1998 through 30 June 2001,
the six state health agencies participating in the PEAS surveillance system received 3,859 calls:
3,768 callers requested information and 91 callers reported symptoms. Five individuals have been
identified as meeting PEAS criteria. Key words: CDC, Centers for Control and Prevention,
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Finally, an important scientiﬁc issue asso-
ciated with surveillance in general, but which
may be more important in environmental
health surveillance, is biological markers (4).
The ability to detect an environmental toxin
in human tissues or verify a biological effect
from such an exposure is critical to identifying
and understanding environmental illnesses.
Pﬁesteria piscicida
An emerging issue in environmental public
health surveillance is human exposure to the
microorganisms present in oceans and estuar-
ies and to the toxins they may produce. One
of these organisms is Pfiesteria piscicida 
Steidinger & Burkholder, a dinoﬂagellate that
has been found in estuaries along the Atlantic
and gulf coasts of the United States (5).
There have been reports of human illness
associated with occupational exposures to
concentrated laboratory cultures of P. pisci-
cida (6) as well as massive fill kills and the
observation of fish with ulcerative lesions
associated with the presence of the organism
in rivers and estuaries (7).
In addition to the published reports, there
were anecdotal reports that environmental
exposure to this organism may impact human
health. In 1997 a small group of people living
and working near a river on the Eastern Shore
of the Chesapeake Bay in Maryland reported
to their health department that they were ill.
Their symptoms included nonspecific com-
plaints such as headaches and skin rashes and
also included neurocognitive complaints such
as problems with memory and concentration.
Fishermen working on a local river that sum-
mer reported seeing a large ﬁsh kill compris-
ing a number of ﬁsh with ulcerative lesions. P.
piscicida was tentatively identified by light
microscopy in water samples collected from
the river. These reports generated concern that
environmental exposures to P. piscicida, simi-
lar organisms, or perhaps a toxin or toxins
produced by the organism(s), could cause
adverse human health effects. To begin to
evaluate the public health burden associated
with exposure to P. piscicida, investigators and
public health ofﬁcials developed a passive sur-
veillance system for collecting, classifying, and
tracking public inquiries about the organism.
Methods
The public health officials from federal and
state health agencies collaborated to develop
the public health response to the presence of
P. piscicida (and similar organisms, hereafter
referred to as Pfiesteria spp.) in estuarine
waters. Surveillance activities were supported
by congressionally mandated funds through
cooperative agreements with Centers for
Disease Control and Prevention (CDC) (8).
First, the group developed a number of work-
ing definitions for the illness, exposure, and
symptoms. The aggregate of exposure and
symptom criteria was called possible estuary-
associated syndrome (PEAS) (9,10).
For surveillance purposes, people meet
PEAS criteria if a) they report that their
symptoms developed within 2 weeks after
self-reported exposure to waters defined by
the relevant state agency as estuarine; b) they
report memory loss or confusion of any
duration or three or more of the following
symptoms: skin rash/sensation of burning
skin at the site of water contact of any
duration; or headache, eye irritation, upper
respiratory irritation, muscle cramps, and
gastrointestinal symptoms, any of which per-
sist for more than 2 weeks; and c) a health-
care provider cannot identify another cause
for the symptoms (9,10).
For the surveillance system we were
specifically interested in trying to document
human environmental exposure to Pfiesteria
spp. However, at that time, there was no efﬁ-
cient way to evaluate exposure because no
toxin had been identiﬁed and the identiﬁca-
tion of the organism itself was costly and
time-consuming (involving long-term labora-
tory culturing and scanning electron
microscopy) (5). The state and federal health
agency representatives agreed to surmise the
presence of P. piscicida, and thus assume
human exposure, under certain circumstances
such as the presence of fish kills for which
there was no other explanation. For PEAS
surveillance, exposure to estuarine water was
considered an indicator of the potential for
exposure to Pﬁesteria spp. Thus, for the PEAS
surveillance activities, exposure was deﬁned as
self-reported work or recreational activities in
or on estuarine water within 2 weeks prior to
onset of symptom(s), or self-reported labora-
tory or aquaculture work involving exposure
to estuarine water or organisms from estuar-
ine waters within 2 weeks prior to symptom
onset (9,10).
Each state participating in the PEAS
surveillance system established a toll-free tele-
phone hotline to provide information to
callers about P. piscicida and similar organ-
isms, exposure to estuarine water, and symp-
toms of PEAS. CDC and the state health
agencies jointly developed questionnaires, a
core data dictionary, and a database program
for state PEAS data collection (11). Some
state health agencies elected to collect addi-
tional information based on circumstances in
their state or to address particular research
interests. To facilitate data entry, the screens
for entering data into the database program
reflected the format of the paper form used
when responding to callers.
The surveillance system was designed to
passively collect information to assess the pub-
lic health burden of exposure and illness associ-
ated with Pﬁesteria spp. The telephone hotlines
provided an entry point to the data collection
system. CDC epidemiologists worked closely
with state health agency representatives to pro-
vide training and technical assistance in imple-
menting the surveillance system.
On 1 June 1998 CDC and the state
health agencies of Delaware, Florida,
Maryland, North Carolina, South Carolina,
and Virginia initiated the passive surveillance
system for PEAS. Callers are triaged through
a complex decision system (Figure 1). People
who call for information are provided with
brochures and other education materials
developed by their state health agencies.
People calling to report symptoms are
administered an interview that includes ques-
tions on demographics, exposure, symptoms,
and related medical care. The purpose of the
interview is to determine, based on exposure
and symptoms, whether an individual should
be referred for further medical evaluation
and to provide a disposition. As part of their
surveillance programs, some state health
agencies refer callers to their personal pri-
mary health care providers for any further
medical care. Other state health agencies
identiﬁed a group of physicians interested in
assessing the health symptoms reported by
people who may have been exposed to
Pfiesteria spp. and provided funding for the
follow-up medical evaluations. 
All calls from people requesting informa-
tion or reporting symptoms that may be
related to Pfiesteria spp. are recorded in the
database. If symptoms are reported, exposure
is assessed by using the established exposure
criteria. If symptoms are reported but expo-
sure to estuarine water is not, the sympto-
matic person receives information about
PEAS and Pﬁesteria spp., and based on state-
specific protocols, may be referred to a
healthcare provider. 
If the caller reports symptoms and expo-
sure to estuarine water, the state representa-
tive administers a telephone questionnaire to
determine if the caller meets symptom crite-
ria. If a person does not meet symptom crite-
ria, the state representative provides the caller
with information about PEAS and Pfiesteria
spp., refers the person to his/her primary
health care provider, and requests that the
person call back if symptoms change or per-
sist. When a person meets PEAS symptom
criteria, the state health agency representative
may (depending on state-specific protocols)
refer the caller to or assist the caller in making
appointments with medical specialists.
Subsequent physician reports may provide
an explanation for the person’s symptoms.
When no alternative explanation can be given
for an exposed individual’s symptoms, the state
health agency representative refers him or her
to the appropriate medical specialists, accord-
ing to the state protocol. A representative fromPossible estuary-associated syndrome surveillance
the state health agency conducts follow-up by
telephone to obtain medical reports and assign
a ﬁnal disposition based on the PEAS symp-
tom and exposure criteria. If the state health
agency is unable to obtain the relevant medical
reports from physicians, the symptomatic
person is considered lost to follow-up.
Surveillance information for the core data
variables is periodically transferred to CDC
for data aggregation and dissemination to the
public in the form of periodic reports in the
Morbidity and Mortality Weekly Review (12).
Results
From 1 June 1998, through 30 June 2001,
the six state health agencies participating in
the PEAS surveillance system received 3,859
calls to request information about P. piscicida
or similar organisms or to report symptoms
(Table 1). Almost all (97.6%) the calls were
requests for information about P. piscicida,
similar organisms, or PEAS. Ninety-one calls
concerned symptomatic people; 66 (73%) of
these people had possible exposure to estuar-
ine water. Of these 66 people, 55 were seen by
or referred to a healthcare provider and five
chose not to seek medical care. Of the 54 peo-
ple who did contact a healthcare provider, 18
had another cause identified for their symp-
toms [e.g., physician-diagnosed insect bites,
impetigo, foliculitis (13)], and four have envi-
ronmental and medical results still pending.
Five individuals have been identified as
meeting PEAS criteria (see “Materials and
Methods” for criteria). The time of exposure,
reported activities, date of symptom onset,
and environmental sampling data for these
ﬁve people are presented in Table 2. Because
most of the fish and water sampling and
analysis was done as part of routine monitor-
ing programs, it is difﬁcult to establish a tem-
poral association between finding fish with
lesions or identifying Pﬁesteria in water sam-
ples and the reported onset of symptoms for
these individuals. For example, for subject 1,
menhaden with lesions were found in the
same general area where the subject had been
engaged in recreational activities. Pfiesteria
was identified in water samples from the
Pocomoke, but the samples were collected
2 months after the reported exposure. For
subject 2, Pﬁesteria was identiﬁed in the water
samples collected soon after the reported
exposure; however, less than 0.5% of the col-
lected menhaden had lesions. For subject 3,
fish and water were sampled at times that
overlapped the reported exposures, but very
few menhaden had lesions, and Pﬁesteria was
not found in the water samples. For subject
4, sampling was conducted 2 months after
the reported exposure and onset of symp-
toms; thus, we do not know if the exposure
involved water containing Pfiesteria or fish
with lesions. Finally, for subject 5, no fish
sampling was done, and few samples were
taken in the rivers where exposure was
reported to occur. Pﬁesteria was not identiﬁed
in the two water samples collected.
Discussion
The development of the PEAS surveillance
system represented a unique challenge to the
public health agencies involved because the
health outcome was a nonspeciﬁc constellation
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Figure 1. Flow of calls in surveillance system.
Table 1. PEAS surveillance results: 1 June 1998–30 June 2001.
Calls to PEAS surveillance system 1998a 1999 2000 2001 Total
Number requesting information only 939 962 1615 252 3,768
Number reporting symptoms 41 33 15 2 91
Total calls 980 995 1,630 254 3,859
Number reporting symptoms and potential estuarine  27 23 14 2 66
water exposure
Number seen by or referred to a healthcare provider 23 18 13 1 55
Number for whom another cause of illness was
identiﬁed and reported by a healthcare provider 8 7 3 0 18
Number with ﬁnal results pending 0 2 2 1 5
Total number of callers meeting PEAS criteriab 113 05
a1 June through 31 December 1998. bFor surveillance purposes, people meet PEAS criteria if a) they report that their symptoms devel-
oped within 2 weeks after self-reported exposure to waters deﬁned by the relevant state agency as estuarine; b) they report memory
loss or confusion of any duration or three or more of the following symptoms: skin rash/sensation of burning skin at the site of water
contact of any duration; or headache, eye irritation, upper respiratory irritation, muscle cramps, and gastrointestinal symptoms, any of
which persist for more than 2 weeks; and c) a healthcare provider cannot identify another cause for the symptoms (9,10).Backer et al.
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of health complaints based on self-reports
from a small group of people. In addition,
exposure could only be surmised from reports
of unexplained ﬁsh kills or ﬁsh with lesions or
the identiﬁcation of P. piscicida in water sam-
ples taken after the fact. Finally, the hazard
was ill-deﬁned as the presence in the water of
P. piscicida itself or of toxin(s) produced by
the organism, similar organisms, or, possibly,
of bacteria or other pathogens that might be
found in association with P. piscicida. 
While PEAS surveillance activities were
being planned and implemented, a consider-
able amount of research effort was simultane-
ously devoted to investigating the biology and
ecology of P. piscicida, whether and under
what circumstances the organism might pro-
duce a toxin or toxins, and what the human
health effects from exposure to the organism
actually were. We expected to revise PEAS
surveillance exposure and symptom criteria as
the scientiﬁc work on Pﬁesteria spp. evolved.
Our ability to detect and identify P. pisci-
cida and similar organisms improved from
1997 to 2001. New assays included a poly-
merase chain reaction–based assay (14) and a
reporter gene assay for toxic activity associ-
ated with the organism (15). However, there
were few improvements in defining human
exposure and symptoms. For example, in
1998 Grattan et al. (16) reported that the
original group of people who may have been
exposed during the late summer of 1997
experienced symptoms that included skin
lesions and measurable neurocognitive diffi-
culties. However, even for this original group
that reported symptoms and potential expo-
sure, a temporal association between symp-
tom onset and the presence of P. piscicida in
the river has not been conﬁrmed.
Efforts to identify a toxin or toxins elabo-
rated by P. piscicida have not yet been suc-
cessful; without something to measure, it is
not possible to conﬁrm that an environmen-
tal exposure has occurred. In addition, with-
out an identiﬁable toxin, we cannot develop
markers of either exposure or biological effect
in people. Thus, the anticipated improve-
ments in defining exposure and symptoms
have not yet occurred.
Despite the difficulties associated with
PEAS surveillance, the surveillance system has
accomplished the important public health
goal of identifying the public health burden
of Pﬁesteria spp. on the state health agencies
that were responsible for responding to
Pﬁesteria spp.–related phone calls over a 37-
month period. The PEAS surveillance system
provides information about estuarine events
that state health agencies can use to make
decisions related to potential Pfiesteria
spp.–related illness and public health. This
information can then be quickly disseminated
to the public. It is interesting to note that
from 1998 through 2000, the number of calls
requesting information increased, while the
number of calls reporting symptoms
decreased. Although these changes probably
reflected the decrease in P. piscicida–related
environmental events (i.e., ﬁsh kills, ﬁsh with
lesions), they probably also reﬂect the efforts
of local health agencies to educate the public.
We anticipate that PEAS surveillance activi-
ties will continue minimally through 2002.
During the period from 1 June 1998
through 30 June 2001(Table 1), only ﬁve of
the individuals who were captured by the sur-
veillance system received a ﬁnal disposition of
PEAS. Five people are still undergoing med-
ical tests, others were lost to follow-up, and
other symptomatic people may have provided
incomplete information (particularly infor-
mation about medical follow-up)or never
reported to the system.
Of the five individuals who met PEAS
criteria, three were in the original group that
reported exposure during the summer of
1997. We attempted to use primarily routine
monitoring data to verify that these individu-
als were exposed to estuarine waters during
ﬁsh kills or at times when Pﬁesteria was found
in the water. However, except for subjects 2
and 3, the monitoring data were not collected
Table 2. Date and description of activities conducted on estuarine waters in Maryland, date of symptoms onset, and date and results from environmental sampling in the
geographic area of the exposure to estuarine waters for individuals meeting PEAS criteria as of 31 January 2001.
Subject Activities Area of activities Date of activities Date of symptoms onset Fish monitoringa Water monitoringb
1 Recreation Pokomoke River Summer 1998 Aug 1998c Lower Pocomoke Lower Pocomoke
15 Jul–15 Aug 1998 Oct 1998
2/4 4/28
4,307 ﬁsh, 43 anomalies
2 Kayaking Back Creek 9 August 1999 9 Aug 1999 Back Creek Back Creek
11 Aug–14 Sept 1999 11–26 Aug 1999
2/2,002 6/9
3 Hobby ﬁshing, Tangier Sound, Oct & Nov 1999 Oct 1999c Tangier Sound Tangier Sound
crabbing, clamming  Back Creek, May & June 2000 No sampling Apr–Oct 2000
Rumbly Point 0/30
Back Creek Back Creek
May–Jun 2000 Jun 2000
2/2,135 0/2
Rumbly Point Rumbly Point
No samples 8 Apr–19 Oct 1999
0/7
4 Water sampling St. Martins 23 June 2000 24 June 2000c Bishopville Prong Bishopville Prong
6–10 Aug 2000 4 & 10 Aug 2000
3/13 0/2
Smith Island 26 June 2000 Smith Island Tangier Sound, 5 miles
No samples south of Smith Island
Apr–Oct 2000
0/10
5 Summer boating Miles River, Apr–Aug 1998, 1 May 2000 Miles River Miles River
Severn River 1999, 2000 No samples No samples
Severn River Severn River
No samples Sept–Oct 1999
0/2
aNumber of menhaden with lesions/number of menhaden examined, unless other species of ﬁsh listed. bNumber of water samples positive for Pﬁesteria/number of water samples analyzed. cThese indi-
viduals were exposed to estuarine water and reported various symptoms in 1997. Their symptoms had resolved (completely or incompletely) over time, and they were again symptomatic on the dates
shown in this table.Possible estuary-associated syndrome surveillance
during the reported exposure period(s). For
subject 2, the ﬁsh and water sampling data did
not identify either a large number of ﬁsh with
lesions or the presence of Pfiesteria in the
water at the time of their reported exposure.
Pfiesteria was identified in samples taken in
Back Creek in Maryland at about the same
time subject 2 reported being there. However,
even in this example, there were only two
lesioned fish among over 2,000 examined.
Thus, it remains difﬁcult to conclude that the
symptoms reported by those meeting PEAS
criteria are related to the presence of Pﬁesteria.
If ongoing research indicates that the deﬁni-
tions of PEAS or that symptom or exposure
criteria should be modiﬁed, the disposition of
some of the people in the surveillance system
may change.
The identiﬁcation of people with PEAS is
certainly dependent upon the existence of the
appropriate environmental and ecological cir-
cumstances. During the P. piscicida “seasons”
(from midsummer through late fall) since the
initiation of PEAS surveillance (June 1998),
there have been few adverse impacts on fish
populations that could be attributed to P. pis-
cicida and very few indications of P. piscicida
blooms (periods of exuberant growth).
Although the reasons for this lack of P. pisci-
cida activity are unclear, it is possible that
upon more careful observation, ﬁsh kills and
the presence of lesions on fish are being
attributed to other causes, including environ-
mental stressors such as suboptimal water
quality (17) or fungal infections (18,19). In
addition, runoff from the massive hurricane-
related ﬂooding in the North Carolina pied-
mont area may have created suboptimal
habitat for this organism, limiting its ability
to impact ﬁsh and/or human health.
Characteristics of the PEAS surveillance
system that may limit its usefulness have been
discussed. The definitions of PEAS and the
criteria for symptoms and exposure are non-
specific and impossible to confirm. In
addition, the system is passive and relies on
public awareness of the system, and the public
obtaining access and providing information to
the system. It is likely that there is underre-
porting of exposures and symptoms that meet
our surveillance deﬁnitions. It is important also
to emphasize that the surveillance system was
designed to assess the burden to the public
health agencies responding to inquiries about
the organism. It was not designed to determine
the human health risk from exposure to estuar-
ine waters, P. piscicida, or similar organisms.
Despite these limitations, the PEAS sys-
tem was successful in contributing to the ﬁeld
of environmental public health surveillance.
The PEAS surveillance system provided valu-
able information about the extent of the bur-
den for state health agencies from public
concern about Pfiesteria spp. Through the
development of the PEAS surveillance system,
several state health agencies have created an
infrastructure allowing them to rapidly
respond to public health events associated
with estuarine exposure that includes multi-
disciplinary teams, a tracking system, and data
collection capacity. Finally, the PEAS surveil-
lance system is a model for conducting public
health surveillance for other environmental
health issues, including the human health
impact from other harmful algal blooms.
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